CN115011660A - Metabolism promoting and oxidation resisting oat protein peptide and preparation method and application thereof - Google Patents
Metabolism promoting and oxidation resisting oat protein peptide and preparation method and application thereof Download PDFInfo
- Publication number
- CN115011660A CN115011660A CN202210946529.7A CN202210946529A CN115011660A CN 115011660 A CN115011660 A CN 115011660A CN 202210946529 A CN202210946529 A CN 202210946529A CN 115011660 A CN115011660 A CN 115011660A
- Authority
- CN
- China
- Prior art keywords
- oat protein
- enzymolysis
- oat
- acetone
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 101100094857 Danio rerio slc22a6 gene Proteins 0.000 title claims abstract description 197
- 101150010952 OAT gene Proteins 0.000 title claims abstract description 197
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 116
- 230000004060 metabolic process Effects 0.000 title claims abstract description 37
- 230000003647 oxidation Effects 0.000 title claims abstract description 36
- 238000007254 oxidation reaction Methods 0.000 title claims abstract description 36
- 230000001737 promoting effect Effects 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 238000000855 fermentation Methods 0.000 claims abstract description 77
- 230000004151 fermentation Effects 0.000 claims abstract description 77
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 63
- 239000011669 selenium Substances 0.000 claims abstract description 63
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 54
- 239000007788 liquid Substances 0.000 claims abstract description 49
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 41
- 241000193749 Bacillus coagulans Species 0.000 claims abstract description 29
- 240000006024 Lactobacillus plantarum Species 0.000 claims abstract description 29
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims abstract description 29
- 229940054340 bacillus coagulans Drugs 0.000 claims abstract description 29
- 229940072205 lactobacillus plantarum Drugs 0.000 claims abstract description 29
- 239000004365 Protease Substances 0.000 claims abstract description 27
- 238000000034 method Methods 0.000 claims abstract description 26
- 108090000145 Bacillolysin Proteins 0.000 claims abstract description 19
- 108091005507 Neutral proteases Proteins 0.000 claims abstract description 19
- 102000035092 Neutral proteases Human genes 0.000 claims abstract description 19
- 108090000526 Papain Proteins 0.000 claims abstract description 19
- 235000019834 papain Nutrition 0.000 claims abstract description 19
- 229940055729 papain Drugs 0.000 claims abstract description 19
- 108091005658 Basic proteases Proteins 0.000 claims abstract description 15
- 108090000284 Pepsin A Proteins 0.000 claims abstract description 15
- 102000057297 Pepsin A Human genes 0.000 claims abstract description 15
- 229940111202 pepsin Drugs 0.000 claims abstract description 15
- 108010007119 flavourzyme Proteins 0.000 claims abstract description 13
- 108091005508 Acid proteases Proteins 0.000 claims abstract description 12
- 241000894006 Bacteria Species 0.000 claims abstract description 9
- 239000003960 organic solvent Substances 0.000 claims abstract description 3
- 239000000243 solution Substances 0.000 claims description 125
- 229940091258 selenium supplement Drugs 0.000 claims description 56
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 51
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 50
- 239000000126 substance Substances 0.000 claims description 48
- 239000012528 membrane Substances 0.000 claims description 44
- 239000000047 product Substances 0.000 claims description 37
- 102000004190 Enzymes Human genes 0.000 claims description 33
- 108090000790 Enzymes Proteins 0.000 claims description 33
- 229940088598 enzyme Drugs 0.000 claims description 33
- 238000001914 filtration Methods 0.000 claims description 31
- 239000000706 filtrate Substances 0.000 claims description 28
- -1 trichloroacetic acid-acetone-acetonitrile Chemical compound 0.000 claims description 28
- 230000003078 antioxidant effect Effects 0.000 claims description 25
- 229930003231 vitamin Natural products 0.000 claims description 22
- 235000013343 vitamin Nutrition 0.000 claims description 22
- 239000011782 vitamin Substances 0.000 claims description 22
- 229940088594 vitamin Drugs 0.000 claims description 22
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 22
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 21
- 238000010438 heat treatment Methods 0.000 claims description 21
- 239000011148 porous material Substances 0.000 claims description 21
- GPEHQHXBPDGGDP-UHFFFAOYSA-N acetonitrile;propan-2-one Chemical compound CC#N.CC(C)=O GPEHQHXBPDGGDP-UHFFFAOYSA-N 0.000 claims description 20
- 239000000413 hydrolysate Substances 0.000 claims description 20
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 19
- 229910001424 calcium ion Inorganic materials 0.000 claims description 19
- 230000000415 inactivating effect Effects 0.000 claims description 19
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 18
- 238000011081 inoculation Methods 0.000 claims description 17
- 206010021143 Hypoxia Diseases 0.000 claims description 16
- 230000002255 enzymatic effect Effects 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 15
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 14
- 239000007864 aqueous solution Substances 0.000 claims description 14
- 238000001035 drying Methods 0.000 claims description 14
- 230000001376 precipitating effect Effects 0.000 claims description 14
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 claims description 14
- 239000003963 antioxidant agent Substances 0.000 claims description 13
- 235000006708 antioxidants Nutrition 0.000 claims description 13
- 239000006166 lysate Substances 0.000 claims description 13
- 238000001471 micro-filtration Methods 0.000 claims description 13
- 238000001728 nano-filtration Methods 0.000 claims description 12
- 238000012258 culturing Methods 0.000 claims description 10
- 238000004108 freeze drying Methods 0.000 claims description 10
- 108060006613 prolamin Proteins 0.000 claims description 10
- XXRYFVCIMARHRS-UHFFFAOYSA-N propan-2-yl n-dimethoxyphosphorylcarbamate Chemical compound COP(=O)(OC)NC(=O)OC(C)C XXRYFVCIMARHRS-UHFFFAOYSA-N 0.000 claims description 10
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 claims description 10
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 9
- 238000005336 cracking Methods 0.000 claims description 9
- 229910052757 nitrogen Inorganic materials 0.000 claims description 9
- 229910052760 oxygen Inorganic materials 0.000 claims description 9
- 239000001301 oxygen Substances 0.000 claims description 9
- 238000000108 ultra-filtration Methods 0.000 claims description 9
- 238000005406 washing Methods 0.000 claims description 9
- 108091005804 Peptidases Proteins 0.000 claims description 8
- 230000009849 deactivation Effects 0.000 claims description 8
- 230000002503 metabolic effect Effects 0.000 claims description 8
- 239000012466 permeate Substances 0.000 claims description 8
- 235000019419 proteases Nutrition 0.000 claims description 8
- 229930003451 Vitamin B1 Natural products 0.000 claims description 7
- 229930003779 Vitamin B12 Natural products 0.000 claims description 7
- 239000004202 carbamide Substances 0.000 claims description 7
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 7
- 239000001569 carbon dioxide Substances 0.000 claims description 7
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 claims description 7
- 238000007873 sieving Methods 0.000 claims description 7
- 239000006228 supernatant Substances 0.000 claims description 7
- 238000009210 therapy by ultrasound Methods 0.000 claims description 7
- 229960003495 thiamine Drugs 0.000 claims description 7
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 7
- 235000010374 vitamin B1 Nutrition 0.000 claims description 7
- 239000011691 vitamin B1 Substances 0.000 claims description 7
- 235000019163 vitamin B12 Nutrition 0.000 claims description 7
- 239000011715 vitamin B12 Substances 0.000 claims description 7
- 235000013312 flour Nutrition 0.000 claims description 6
- 230000004580 weight loss Effects 0.000 claims description 6
- 230000003213 activating effect Effects 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 5
- 230000009089 cytolysis Effects 0.000 claims description 5
- 239000002609 medium Substances 0.000 claims description 5
- 238000004260 weight control Methods 0.000 claims description 4
- 239000000796 flavoring agent Substances 0.000 claims description 3
- 235000019634 flavors Nutrition 0.000 claims description 3
- 230000004913 activation Effects 0.000 claims description 2
- 239000001963 growth medium Substances 0.000 claims description 2
- 230000007954 hypoxia Effects 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims 2
- 206010002660 Anoxia Diseases 0.000 claims 1
- 241000976983 Anoxia Species 0.000 claims 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 1
- 230000007953 anoxia Effects 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 44
- 108090000623 proteins and genes Proteins 0.000 abstract description 34
- 102000004169 proteins and genes Human genes 0.000 abstract description 34
- 230000000694 effects Effects 0.000 abstract description 31
- 239000008280 blood Substances 0.000 abstract description 18
- 210000004369 blood Anatomy 0.000 abstract description 18
- 108010038807 Oligopeptides Proteins 0.000 abstract description 17
- 102000015636 Oligopeptides Human genes 0.000 abstract description 17
- 229920001184 polypeptide Polymers 0.000 abstract description 17
- 239000013522 chelant Substances 0.000 abstract description 14
- 230000037396 body weight Effects 0.000 abstract description 13
- 230000001603 reducing effect Effects 0.000 abstract description 10
- 230000006870 function Effects 0.000 abstract description 6
- 206010061218 Inflammation Diseases 0.000 abstract description 5
- 230000036772 blood pressure Effects 0.000 abstract description 5
- 230000003467 diminishing effect Effects 0.000 abstract description 5
- 230000036039 immunity Effects 0.000 abstract description 5
- 230000004054 inflammatory process Effects 0.000 abstract description 5
- 230000002708 enhancing effect Effects 0.000 abstract description 4
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 33
- 235000018102 proteins Nutrition 0.000 description 32
- 230000000052 comparative effect Effects 0.000 description 23
- 230000002829 reductive effect Effects 0.000 description 21
- 239000000523 sample Substances 0.000 description 13
- 238000002835 absorbance Methods 0.000 description 12
- 150000003254 radicals Chemical class 0.000 description 12
- 241000699670 Mus sp. Species 0.000 description 9
- 230000009467 reduction Effects 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 8
- 102000008186 Collagen Human genes 0.000 description 8
- 108010035532 Collagen Proteins 0.000 description 8
- 230000002378 acidificating effect Effects 0.000 description 8
- 150000001413 amino acids Chemical class 0.000 description 8
- 229920001436 collagen Polymers 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 8
- 230000006872 improvement Effects 0.000 description 8
- 102000035195 Peptidases Human genes 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 6
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 6
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 6
- 230000001276 controlling effect Effects 0.000 description 6
- 230000007935 neutral effect Effects 0.000 description 6
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 6
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 6
- 108010073771 Soybean Proteins Proteins 0.000 description 5
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 238000000751 protein extraction Methods 0.000 description 5
- 239000012488 sample solution Substances 0.000 description 5
- 108010016626 Dipeptides Proteins 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 4
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 4
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 4
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 4
- 230000003064 anti-oxidating effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 235000009200 high fat diet Nutrition 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- OLYFZPNPLNSOMA-UHFFFAOYSA-N propan-2-one;2,2,2-trichloroacetic acid Chemical compound CC(C)=O.OC(=O)C(Cl)(Cl)Cl OLYFZPNPLNSOMA-UHFFFAOYSA-N 0.000 description 4
- 150000003384 small molecules Chemical class 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 230000002292 Radical scavenging effect Effects 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000007760 free radical scavenging Effects 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 229940079877 pyrogallol Drugs 0.000 description 3
- 229940001941 soy protein Drugs 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004899 c-terminal region Anatomy 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 230000001066 destructive effect Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000005714 functional activity Effects 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 125000001841 imino group Chemical group [H]N=* 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000002366 mineral element Substances 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 238000005502 peroxidation Methods 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 239000006041 probiotic Substances 0.000 description 2
- 235000018291 probiotics Nutrition 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000006950 reactive oxygen species formation Effects 0.000 description 2
- 235000019710 soybean protein Nutrition 0.000 description 2
- 229910001428 transition metal ion Inorganic materials 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 239000002351 wastewater Substances 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 1
- 108010039627 Aprotinin Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000005593 Endopeptidases Human genes 0.000 description 1
- 108010059378 Endopeptidases Proteins 0.000 description 1
- 102000018389 Exopeptidases Human genes 0.000 description 1
- 108010091443 Exopeptidases Proteins 0.000 description 1
- BCCRXDTUTZHDEU-VKHMYHEASA-N Gly-Ser Chemical compound NCC(=O)N[C@@H](CO)C(O)=O BCCRXDTUTZHDEU-VKHMYHEASA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000003916 acid precipitation Methods 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229960004405 aprotinin Drugs 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000007065 protein hydrolysis Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000004065 wastewater treatment Methods 0.000 description 1
- 239000013585 weight reducing agent Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A23L33/165—Complexes or chelates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/145—Extraction; Separation; Purification by extraction or solubilisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/30—Extraction; Separation; Purification by precipitation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P39/00—Processes involving microorganisms of different genera in the same process, simultaneously
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/25—Lactobacillus plantarum
Abstract
The invention provides an oat protein peptide with the functions of promoting metabolism and resisting oxidation, and a preparation method and application thereof, and belongs to the technical field of protein peptides. The method comprises the steps of crushing oat, extracting by using an organic solvent to obtain oat protein, carrying out primary enzymolysis by using pepsin and acid protease, carrying out secondary enzymolysis by using neutral protease and papain, carrying out tertiary enzymolysis by using alkaline protease and flavourzyme to obtain a tertiary oat protein enzymolysis liquid, fermenting by using lactobacillus plantarum and bacillus coagulans to obtain a primary oat protein fermentation product, and fermenting by using selenium-enriched yeast to obtain the metabolism promoting and oxidation resisting oat protein peptide. The product prepared by the invention contains rich short peptides, oligopeptides, polypeptides and oat protein peptide-selenium chelate, has excellent effects of promoting metabolism, resisting oxidation, diminishing inflammation, resisting bacteria, enhancing immunity, reducing blood pressure, blood fat and blood sugar, losing weight and fat and controlling body weight, is simple in preparation method, has good effect, and can be applied to preparation of products for losing weight and controlling body weight.
Description
Technical Field
The invention relates to the technical field of protein peptides, in particular to oat protein peptide capable of promoting metabolism and resisting oxidation, and a preparation method and application thereof.
Background
The peptide is formed by dehydration condensation of 2 or more than 2 amino acids, is a fragment of a protein mechanism and function, enables the protein to have various physiological functions, and has strong special physiological functions. The peptide is formed by dehydration condensation of 2 or 3 amino acids, which are respectively dipeptide and tripeptide, and so on, tetrapeptide, pentapeptide and the like. Generally, the number of amino acids in a peptide chain is 10 or less, 10 to 50 are polypeptides, and 50 or more are proteins. The polypeptide is an active substance and a nutrient substance which exist in the human body and are necessary, is almost widely distributed in the whole body of animals and human beings, particularly the brain, and has a regulating effect on used cells, such as deletion, and disorder of an immune system and various functional systems can occur.
The traditional protein extraction method adopts an alkali dissolution and acid precipitation method, obtains separated protein, and then prepares hydrolyzed protein peptide through hydrolysis of an enzyme preparation, and the production period is long; the environment is not friendly: a large amount of acid and alkali are used in the industrial production process, so that environmental pollution to a certain degree can be caused; large amount of waste water: the traditional industrial production method has the disadvantages of large wastewater discharge amount, high salt content, large wastewater treatment difficulty and high operation cost. Meanwhile, plant polypeptide products in the market have large average molecular weight, the ratio of molecular weight in a specific interval is not controllable, and the action mechanisms and the action effects of polypeptides with different molecular weights are different, so that the controllability of the functions of the polypeptides is poor.
Chinese patent CN103243144B discloses collagen powder rich in collagen tripeptide and a preparation process thereof. The invention aims to provide collagen powder rich in collagen tripeptide and a preparation process of the collagen powder. The fish skin with low fat content is selected as the raw material, and the method omits the soaking in dilute alkali solution to remove fat in the preparation process, thereby reducing harmful substances generated by acid-base treatment; in addition, after the fish skin is subjected to enzymolysis by adopting protease and flavor enzyme sold in the market, part of protein peptide is further degraded into collagen tripeptide by adopting self-made collagenase, so that not only can the extraction rate of collagen in the raw material be improved, but also the functionality of the collagen powder is obviously improved
Japanese patent laid-open publication No. 2005-80668 discloses: provided is a soybean protein hydrolysis method which hydrolyzes soybean protein using an enzyme having both endo-and exo-peptidase activities, thereby increasing the soluble fraction, avoiding the bitter fraction, and enhancing or improving the antioxidant ability. However, the soluble soy protein fraction described in this patent contains about 3kDa to 30kDa peptides and is substantially free of low molecular weight soy proteins. As is not described in this patent, in soy proteins, dipeptides and tripeptides are best absorbed in the intestinal tract, and larger peptides are often difficult to absorb directly. Therefore, the peptide described in this patent is too large to be absorbed and is not considered to be practical because it does not exhibit a significant action in vivo. Furthermore, the peptide described in Japanese patent application laid-open No. 10-203994 also has a size of 500-5000A, and is considered to be impractical because it is too large as compared with the dipeptide and tripeptide.
Disclosure of Invention
The oat protein peptide contains rich short peptides, oligopeptides, polypeptides and oat protein peptide-selenium chelate, has excellent effects of promoting metabolism, resisting oxidation, diminishing inflammation, resisting bacteria, enhancing immunity, reducing blood pressure, blood fat, blood sugar, weight and fat and controlling body weight, is simple in preparation method, has a good effect, and can be applied to preparation of products for weight reduction and weight control.
The technical scheme of the invention is realized as follows:
the invention provides a preparation method of oat protein peptide for promoting metabolism and resisting oxidation, which comprises the steps of crushing oat, extracting by using an organic solvent to obtain oat protein, carrying out primary enzymolysis by using pepsin and acid protease, carrying out secondary enzymolysis by using neutral protease and papain, carrying out tertiary enzymolysis by using alkaline protease and flavourzyme to obtain a tertiary enzymolysis liquid of the oat protein, fermenting by using lactobacillus plantarum and bacillus coagulans to obtain a primary fermentation product of the oat protein, and fermenting by using selenium-enriched yeast to obtain the oat protein peptide for promoting metabolism and resisting oxidation.
As a further improvement of the invention, the method comprises the following steps:
s1, extracting oat protein: cleaning oat, drying, crushing, sieving to obtain oat powder, adding the oat powder into trichloroacetic acid-acetone-acetonitrile solution, uniformly mixing, precipitating for a first time period, centrifuging, adding insoluble substances into the acetone-acetonitrile solution, uniformly mixing, precipitating for a second time period, centrifuging, washing the insoluble substances, drying, adding the insoluble substances into a lysate for cracking, taking supernatant, and concentrating by using an ultrafiltration membrane to obtain an oat protein extracting solution;
s2, primary enzymolysis: adjusting the pH value of the oat protein extract prepared in the step S1 to 2.5-3.5, heating to the temperature of 35-40 ℃, adding pepsin and acid protease, performing enzymolysis, inactivating enzymes, and filtering to obtain a filtrate, namely an oat protein first-level enzymolysis liquid;
s3, secondary enzymolysis: adjusting the pH value of the first-stage oat protein enzymolysis liquid prepared in the step S2 to 6.5-7, heating to 50-55 ℃, adding neutral protease and papain, performing enzymolysis, inactivating enzymes, and filtering to obtain a filtrate, namely a second-stage oat protein enzymolysis liquid;
s4, three-stage enzymolysis: adjusting the pH value of the filtrate obtained in the step S3 to be the second-level enzymatic hydrolysate of the oat protein to be 8-9, heating to the temperature of 45-55 ℃, adding alkaline protease and flavourzyme, carrying out enzymolysis, enzyme deactivation and filtration, wherein the filtrate is the third-level enzymatic hydrolysate of the oat protein;
s5, activating strains: respectively inoculating lactobacillus plantarum, bacillus coagulans and selenium-enriched yeast to a Gauss culture medium, culturing under a micro-anoxic condition, and respectively culturing into strain seed solutions;
s6, primary fermentation: inoculating strain seed solutions of lactobacillus plantarum and bacillus coagulans to the oat protein three-level enzymatic hydrolysate prepared in the step S4, and performing fermentation culture under a micro-anoxic condition to obtain an oat protein first-level fermentation product;
s7, secondary fermentation: inoculating the selenium-enriched yeast strain seed liquid to the oat protein primary fermentation product prepared in the step S6, adding a solution containing calcium ions, carrying out fermentation culture under the condition of hypoxia for a third time period, then adding a vitamin solution, continuing fermentation culture for a fourth time period, filtering by a microfiltration membrane, separating and removing non-hydrolyzed insoluble components which cannot penetrate through the membrane, then concentrating by a nanofiltration membrane, and carrying out freeze drying to prepare the metabolism promoting and oxidation resisting oat protein peptide.
In step S7, the stress resistance of the selenium-enriched yeast is improved and the fermentation time of the selenium-enriched yeast is prolonged by adding the calcium ion solution, and after the selenium-enriched yeast is fermented for a period of time, the vitamin solution is added to prolong the stabilization period of the selenium-enriched yeast, so that a large amount of beneficial products including oat protein peptide-selenium chelate can be produced, and the yield of the product is improved.
As a further improvement of the invention, the solid-to-liquid ratio of the oat flour and the trichloroacetic acid-acetone-acetonitrile solution in the step S1 is 1: 3-5 g/mL; trichloroacetic acid in the trichloroacetic acid-acetone-acetonitrile solution: acetone: the volume ratio of the acetonitrile is 0.5-1: 7-12: 3-5; the solid-liquid ratio of the insoluble substances to the acetone-acetonitrile solution is 1:2-4g/mL, and the ratio of acetone in the acetone-acetonitrile solution is as follows: the volume ratio of the acetonitrile is 3-5: 4-7; the first time period is 0.5-1.5 h; the second time period is 1-2 h; the lysis solution is an aqueous solution containing 3-5mol/L urea, 1-2mol/L thiourea and 0.5-1wt% dithiothreitol; the cracking time is 2-4 h; the solid-liquid ratio of the insoluble substance to the lysate is 1:2-5 g/mL; the pore diameter of the ultrafiltration membrane is 3000-5000D.
As a further improvement of the invention, the mass ratio of the oat protein extract, the pepsin and the acid protease in the step S2 is 100:1-5: 3-7; the enzymolysis time is 1-3 h; in the step S3, the mass ratio of the oat protein primary enzymolysis liquid to the neutral protease to the papain is 100:2-5:3-6, and the enzymolysis time is 2-4 h; in the step S4, the mass ratio of the oat protein secondary enzymolysis liquid to the neutral protease to the papain is 100:3-5:1-3, and the enzymolysis time is 0.5-1.5 h.
As a further improvement of the invention, the micro-anoxic condition comprises 5-12% of oxygen, 3-5% of carbon dioxide and the balance of nitrogen, wherein the percentage is volume percentage; the enzyme deactivation method comprises 1000-1500W ultrasonic treatment for 15-20 min.
As a further improvement of the invention, the culture temperature in the step S5 is 35-40 ℃, and the culture time is 18-24h, soThe strain seed liquid has a bacteria content of 10 7 -10 9 cfu/mL; in the step S6, the inoculation amounts of the lactobacillus plantarum and the bacillus coagulans are respectively 2-5% and 1-3%; the fermentation culture condition is that the temperature is 36-38 deg.C, and the time is 24-36 h.
As a further improvement of the invention, the inoculation amount of the selenium-enriched yeast in the step S7 is 3-5%, and the volume ratio of the oat protein primary fermentation product, the solution containing calcium ions and the vitamin solution is 10: 1-2: 0.5 to 1; the calcium ion concentration in the solution containing calcium ions is 5-12wt%, and the vitamin solution is an aqueous solution containing 2-5wt% of vitamin B1 and 1-3wt% of vitamin B12; the fermentation culture condition is 36-38 ℃, and the third time period is 12-18 h; the fourth time period is 18-24 h; the aperture range of the micro-filtration membrane is 0.1-0.5 mu m, and the aperture range of the nano-filtration membrane is not more than 2 nm.
As a further improvement of the invention, the method specifically comprises the following steps:
s1, extracting oat protein: washing oat, drying, crushing and sieving to obtain oat powder, adding the oat powder into trichloroacetic acid-acetone-acetonitrile solution, wherein the solid-to-liquid ratio of the oat powder to the trichloroacetic acid-acetone-acetonitrile solution is 1: 3-5g/mL, wherein the ratio of trichloroacetic acid in the trichloroacetic acid-acetone-acetonitrile solution is as follows: acetone: the volume ratio of acetonitrile is 0.5-1: 7-12:3-5, uniformly mixing, precipitating for 0.5-1.5h, centrifuging, adding an insoluble substance into an acetone-acetonitrile solution, wherein the solid-to-liquid ratio of the insoluble substance to the acetone-acetonitrile solution is 1:2-4g/mL, and the mass ratio of acetone in the acetone-acetonitrile solution is as follows: the volume ratio of acetonitrile is 3-5:4-7, uniformly mixing, precipitating for 1-2h, centrifuging, washing insoluble substances, drying, adding the dried insoluble substances into a lysate for cracking for 2-4h, wherein the solid-to-liquid ratio of the insoluble substances to the lysate is 1:2-5g/mL, the lysate is an aqueous solution containing 3-5mol/L urea, 1-2mol/L thiourea and 0.5-1wt% dithiothreitol, taking supernatant, and concentrating through an ultrafiltration membrane with the pore diameter of 3000-;
s2, primary enzymolysis: adjusting the pH value of 100 parts by weight of the oat protein extract prepared in the step S1 to 2.5-3.5, heating to the temperature of 35-40 ℃, adding 1-5 parts by weight of pepsin and 3-7 parts by weight of acid protease, performing enzymolysis for 1-3h, inactivating enzymes, and filtering to obtain a filtrate, namely an oat protein first-stage enzymolysis liquid;
s3, secondary enzymolysis: adjusting the pH value of 100 parts by weight of the first-stage enzymatic hydrolysate of the oat protein prepared in the step S2 to 6.5-7, heating to 50-55 ℃, adding 2-5 parts by weight of neutral protease and 3-6 parts by weight of papain, carrying out enzymolysis for 2-4h, inactivating enzyme, and filtering to obtain filtrate which is a second-stage enzymatic hydrolysate of the oat protein;
s4, three-stage enzymolysis: adjusting the pH value of 100 parts by weight of the filtrate obtained in the step S3 to 8-9 of the oat protein secondary enzymolysis liquid, heating to 45-55 ℃, adding 3-5 parts by weight of alkaline protease and 1-3 parts by weight of flavor protease, carrying out enzymolysis for 0.5-1.5h, inactivating enzymes, filtering, and obtaining the filtrate which is the oat protein tertiary enzymolysis liquid;
s5, activating strains: inoculating Lactobacillus plantarum, Bacillus coagulans and selenium-rich yeast to Gao's medium, culturing at 35-40 deg.C under anoxic condition for 18-24 hr, respectively, to obtain strain seed solution with a bacteria content of 10 7 -10 9 cfu/mL;
S6, primary fermentation: inoculating strain seed solutions of lactobacillus plantarum and bacillus coagulans to the oat protein three-level enzymolysis solution prepared in the step S4, wherein the inoculation amounts of the lactobacillus plantarum and the bacillus coagulans are respectively 2-5% and 1-3%, and performing fermentation culture for 24-36h at the temperature of 36-38 ℃ under the condition of micro-hypoxia to obtain an oat protein first-level fermentation product;
s7, secondary fermentation: inoculating selenium-enriched yeast strain seed liquid to 10 volume parts of the oat protein primary fermentation product prepared in the step S6, wherein the inoculation amount of the selenium-enriched yeast is 3-5%, adding 1-2 volume parts of a solution containing 5-12wt% of calcium ions, performing fermentation culture at 36-38 ℃ for 12-18h under the condition of micro-hypoxia, then adding 0.5-1 volume part of a vitamin solution, wherein the vitamin solution is an aqueous solution containing 2-5wt% of vitamin B1 and 1-3wt% of vitamin B12, continuing fermentation culture at 36-38 ℃ for 18-24h, filtering through a microfiltration membrane with the pore size of 0.1-0.5 mu m, separating and removing non-hydrolyzed insoluble components which cannot permeate through the membrane, then concentrating through a nanofiltration membrane with the pore size of not more than 2nm, freeze-drying, preparing oat protein peptide with metabolism promoting and antioxidant effects;
the micro-anoxic condition comprises 5-12% of oxygen, 3-5% of carbon dioxide and the balance of nitrogen, wherein the volume percentage is;
the enzyme deactivation method comprises 1000-1500W ultrasonic treatment for 15-20 min.
The invention further protects the oat protein peptide with the functions of promoting metabolism and resisting oxidation, which is prepared by the preparation method.
The invention further protects the application of the oat protein peptide for promoting metabolism and resisting oxidation in preparing products for losing weight and controlling body weight.
The invention has the following beneficial effects: the oat flour is directly extracted by trichloroacetic acid-acetone-acetonitrile solution/acetone-acetonitrile solution for the second time, the trichloroacetic acid-acetone-acetonitrile solution is adopted to replace the traditional trichloroacetic acid-acetone solution, the protein extraction rate is higher, nitrogen elements on cyano groups contained in the adopted acetonitrile are easy to form hydrogen bond with carboxylic acid structures of protein amino acids, so that the protein in the oat flour is promoted to be extracted and precipitated in the presence of acetone, the extraction time is short, the repetition rate is high, the influence of metabolic substances in a sample can be reduced, and the protein loss can be reduced;
further, the prepared oat protein extract is respectively subjected to enzymolysis under acidic, neutral and alkaline conditions, and is subjected to enzymolysis by pepsin and acidic protease which are suitable for acidity under the acidic condition, the proportion of small-molecule peptides in hydrolysate is very high, and the produced polypeptides are almost all small-molecule peptides; under neutral conditions, the enzymolysis is carried out by neutral protease suitable for neutral and papain, the neutral protease is a metal protease, the peptide bond between leucine and phenylalanine is preferentially cut, the papain can decompose the peptide bond in a hydrophobic region, including threonine, tryptophan, phenylalanine and the like, the hydrolysis degree of the enzymolysis product is high, the antioxidant activity is high, under alkaline conditions, the enzymolysis is carried out by alkaline protease suitable for alkaline and flavourzyme, the alkaline protease can decompose the peptide bond, including phenylalanine, tyrosine, tryptophan and lysine carboxyl, and the flavourzyme can preferentially break the peptide bond between leucine and proline or between proline and proline; the enzymolysis speed is high, the enzymolysis effect is good, the yield of hydrolysate small peptides is high, the polypeptide after enzymolysis has higher emulsification stability, after three-stage enzymolysis, most of oat protein in the oat protein extracting solution is enzymolyzed into small molecular short peptides and oligopeptide substances, and the oat protein extracting solution has excellent antioxidant activity;
the prepared third-level enzymolysis liquid of the oat protein also comprises a plurality of long-chain protein molecules and unhydrolyzed protein, lactobacillus plantarum and bacillus coagulans are further added for fermentation, probiotics further ferment and hydrolyze the protein molecules, and most of the unhydrolyzed long-chain protein is hydrolyzed into amino acid, short peptide, oligopeptide or polypeptide substances, so that a first-level fermentation product of the oat protein is prepared;
then, adding selenium-enriched yeast into the oat protein primary fermentation product, further performing enzymolysis, and simultaneously chelating the product polypeptide with selenium mineral elements in organic selenium substances to form oat protein peptide-selenium chelate, wherein the oat protein peptide-selenium chelate is formed by mutual coordination between the selenium element and N-terminal amino, amino acid side chain, C-terminal carboxyl and carbonyl and imino in a peptide chain in the oat protein peptide. Compared with a chelate formed by the interaction of simple amino acid and selenium element, the chelate of the oat protein peptide and the selenium element has better stability and matching rate, has the advantages of high biological benefit, excellent absorption effect, excellent nutrition and the like, and can combine the complementary functional activities of the oat protein peptide and the selenium element, such as metabolism promotion, oxidation resistance, inflammation diminishing, bacteria resistance, immunity enhancement, blood pressure reduction, blood fat reduction, blood sugar reduction, weight losing, fat reduction, weight control and the like.
The oat protein peptide with the functions of promoting metabolism and resisting oxidation, which is prepared by the method disclosed by the invention, comprises an oat protein peptide-selenium chelate, and the oat protein peptide has an excellent anti-oxidation effect after detection, wherein most of the oat protein peptide is short peptide and oligopeptide substances with low molecular weight, and the short peptide and oligopeptide substances with low molecular weight are more easily close to free radicals than bulky parent proteins of the oat protein peptide and oligopeptide substances, and can inhibit peroxidation mediated by the free radicals. The short peptide and oligopeptide substances provide hydrogen atoms or electrons through peptide bonds and hydroxyl groups of the substances, and free radicals lacking hydrogen ions or electrons are eliminated, so that the destructive effect on biological molecules is eliminated; at the same time, the formation of ROS and free radicals can be inhibited by inhibiting certain pro-oxidases and chelating transition metal ions involved in catalyzing the generation of free radicals. The short peptide and oligopeptide substances can also inhibit the conversion of free radicals into hydrogen peroxide, and can be decomposed into harmless metabolites such as water and oxygen by endogenous antioxidants (including superoxide dismutase, catalase and glutathione), thereby having high antioxidant effect.
The oat protein peptide for promoting metabolism and resisting oxidation contains rich short peptide, oligopeptide, polypeptide and oat protein peptide-selenium chelate, has excellent effects of promoting metabolism, resisting oxidation, diminishing inflammation, resisting bacteria, enhancing immunity, reducing blood pressure, reducing blood fat, reducing blood sugar, losing weight and fat and controlling body weight, has a simple preparation method, has a good effect, and can be applied to preparation of products for losing weight and controlling body weight.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below, and it is obvious that the drawings in the following description are only some embodiments of the present invention, and for those skilled in the art, other drawings can be obtained according to these drawings without creative efforts.
FIG. 1 is a graph showing the change of body weight with time in each group of mice in test example 4 of the present invention.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The pepsin is provided by Cangzhou summer enzyme biotechnology limited, 10 ten thousand U/g, the optimum pH value is 2.0-3.0, and the optimum temperature is 30-50 ℃. The acidic protease is provided by bioscience and technology Limited liability company of Henghuadao, Dongning, 3 ten thousand U/g, the optimum pH value is 2.5-3.5, and the optimum temperature is 30-40 ℃. The neutral protease is provided by Nanning Dong Henghuadao biological science and technology Limited liability company, and has an optimum pH value of 20 ten thousand U/g, an optimum pH value of 6.5-7.5, and an optimum temperature of 40-50 deg.C. The papain is provided by Nanning Dong Henghuadao biological science and technology Limited liability company, 10 ten thousand U/g, 99.5% of enzyme activity preservation rate, 7.0-8.0 of optimum pH value and 50-55 ℃ of optimum temperature. The alkaline protease is provided by bioscience and technology Limited liability company of Henghuadao, Dongning, 20 ten thousand U/g, the optimum pH value is 9-12, and the optimum temperature is 40-55 ℃. The flavourzyme is provided by Nanning Dong Henghuadao biological science and technology Limited liability company, 5 ten thousand U/g, the optimum pH value is 5-9, and the optimum temperature is 50-55 ℃.
Lactobacillus plantarum was provided by Weifang Rui Biotechnology Co., Ltd, 50 hundred million cfu/g; the bacillus coagulans is provided by the biological technology company Limited in the exhibition of Xian, 100 hundred million cfu/g, the selenium-rich yeast is provided by the biological technology company Limited in the Jiaodong Jiaoyang, and the selenium content is more than 300mg/kg, wherein the content of organic selenium is more than 95 percent.
In the examples, each step is independent of the other, and the above steps may be repeated several times before the next step is performed to obtain a suitable amount of the product.
Unit D is short for dalton.
Example 1
The embodiment provides a metabolism promoting and antioxidant oat protein peptide, which specifically comprises the following steps:
s1, extracting oat protein: cleaning 100g of oat, drying, crushing, sieving with a 100-mesh sieve to obtain oat powder, adding into 300mL of trichloroacetic acid-acetone-acetonitrile solution, uniformly mixing, precipitating for 0.5h, centrifuging at 10000r/min for 10min, and adding 70g of insoluble substances into 140mL of acetone-acetonitrile solution; mixing, precipitating for 1h, centrifuging at 10000r/min for 10min, washing 50g of insoluble substance, drying at 60 deg.C for 2h, adding 100mL of lysate for cracking for 2h, collecting supernatant, and concentrating with ultrafiltration membrane with pore diameter of 3000D to obtain oat protein extract;
the lysis solution is an aqueous solution containing 3mol/L urea, 1mol/L thiourea and 0.5wt% dithiothreitol;
trichloroacetic acid in the trichloroacetic acid-acetone-acetonitrile solution: acetone: the volume ratio of acetonitrile is 0.5: 7: 3;
acetone in the acetone-acetonitrile solution: the volume ratio of the acetonitrile is 3: 4;
s2, primary enzymolysis: adjusting the pH value of 100g of the oat protein extract prepared in the step S1 to 2.5, heating to the temperature of 35 ℃, adding 1g of pepsin and 3g of acid protease, performing enzymolysis for 1 hour, inactivating enzymes, and filtering to obtain a filtrate, namely a first-stage enzymolysis liquid of the oat protein;
s3, secondary enzymolysis: adjusting the pH value of 100g of the first-stage enzymatic hydrolysate of the oat protein prepared in the step S2 to 6.5, heating to 50 ℃, adding 2g of neutral protease and 3g of papain, carrying out enzymolysis for 2h, inactivating enzymes, and filtering to obtain a filtrate, namely a second-stage enzymatic hydrolysate of the oat protein;
s4, three-stage enzymolysis: adjusting the pH value of 100g of the filtrate prepared in the step S3 to be the oat protein secondary enzymolysis liquid to be 8, heating to the temperature of 45 ℃, adding 3g of alkaline protease and 1g of flavourzyme, carrying out enzymolysis for 0.5h, inactivating enzyme, and filtering to obtain a filtrate which is oat protein tertiary enzymolysis liquid;
s5, activating strains: inoculating Lactobacillus plantarum, Bacillus coagulans and selenium-rich yeast to Gao's medium, culturing under anoxic condition at 35 deg.C for 18 hr to obtain strain seed solution with a strain content of 10 7 cfu/mL;
S6, primary fermentation: inoculating strain seed solutions of lactobacillus plantarum and bacillus coagulans to 100mL of the oat protein three-level enzymolysis solution prepared in the step S4, wherein the inoculation amounts of the lactobacillus plantarum and the bacillus coagulans are respectively 2% and 1%, and performing fermentation culture at the temperature of 36 ℃ for 24h under the condition of micro-hypoxia to obtain an oat protein first-level fermentation product;
s7, secondary fermentation: inoculating selenium-enriched yeast strain seed liquid to 100mL of oat protein primary fermentation product prepared in the step S6, wherein the inoculation amount of the selenium-enriched yeast is 3%, adding 10mL of calcium chloride solution containing 5wt% of calcium ions, performing fermentation culture at 36 ℃ for 12h under the condition of micro-hypoxia, then adding 5mL of vitamin solution, continuing fermentation culture at 36 ℃ for 18h, filtering through a microfiltration membrane with the pore size range of 0.1 mu m, separating and removing unhydrolyzed insoluble components which cannot permeate the membrane, concentrating through a nanofiltration membrane with the pore size range of not more than 2nm, and performing freeze drying to prepare metabolism promoting and oxidation resisting oat protein peptide;
the vitamin solution is an aqueous solution containing 2wt% of vitamin B1 and 1wt% of vitamin B12;
the micro-anoxic condition comprises 5% of oxygen, 3% of carbon dioxide and the balance of nitrogen, wherein the volume percentage is;
the enzyme deactivation method is 1000W ultrasonic treatment for 15 min.
Example 2
The embodiment provides a metabolism promoting and antioxidant oat protein peptide, which specifically comprises the following steps:
s1, extracting oat protein: cleaning 100g of oat, drying, crushing, sieving with a 100-mesh sieve to obtain oat powder, adding into 500mL of trichloroacetic acid-acetone-acetonitrile solution, uniformly mixing, precipitating for 1.5h, centrifuging at 10000r/min for 10min, and adding 75g of insoluble substances into 300mL of acetone-acetonitrile solution; mixing uniformly, precipitating for 2h, centrifuging at 10000r/min for 10min, washing 60g of insoluble substances, drying at 60 ℃ for 2h, adding 300mL of lysate for cracking for 4h, taking supernatant, and concentrating by an ultrafiltration membrane with the pore diameter of 5000D to obtain an oat protein extract;
the lysis solution is an aqueous solution containing 5mol/L urea, 2mol/L thiourea and 1wt% dithiothreitol;
trichloroacetic acid in the trichloroacetic acid-acetone-acetonitrile solution: acetone: the volume ratio of acetonitrile is 1: 12: 5;
acetone in the acetone-acetonitrile solution: the volume ratio of the acetonitrile is 5: 7;
s2, primary enzymolysis: adjusting the pH value of 100g of the oat protein extract prepared in the step S1 to 3.5, heating to 40 ℃, adding 5g of pepsin and 7g of acid protease, performing enzymolysis for 3 hours, inactivating enzymes, and filtering to obtain a filtrate, namely a first-stage enzymolysis solution of the oat protein;
s3, secondary enzymolysis: adjusting the pH value of 100g of the first-stage enzymatic hydrolysate of the oat protein prepared in the step S2 to 7, heating to 55 ℃, adding 5g of neutral protease and 6g of papain, carrying out enzymolysis for 4h, inactivating enzymes, and filtering to obtain a filtrate, namely a second-stage enzymatic hydrolysate of the oat protein;
s4, three-stage enzymolysis: adjusting the pH value of 100g of the filtrate prepared in the step S3 to 9, heating to 55 ℃, adding 5g of alkaline protease and 3g of flavourzyme, performing enzymolysis for 1.5h, inactivating enzyme, and filtering to obtain a filtrate, namely a third-level enzymolysis solution of the oat protein;
s5, strain activation: inoculating Lactobacillus plantarum, Bacillus coagulans and selenium-rich yeast to Gao's medium, culturing under anoxic condition at 40 deg.C for 24 hr to obtain strain seed solution with a strain content of 10 9 cfu/mL;
S6, primary fermentation: inoculating strain seed solutions of lactobacillus plantarum and bacillus coagulans into 100mL of the oat protein three-level enzymolysis solution prepared in the step S4, wherein the inoculation amounts of the lactobacillus plantarum and the bacillus coagulans are respectively 5% and 3%, and performing fermentation culture at 38 ℃ for 36h under the condition of micro-hypoxia to obtain an oat protein first-level fermentation product;
s7, secondary fermentation: inoculating a selenium-enriched yeast strain seed solution to 100mL of the oat protein primary fermentation product prepared in the step S6, wherein the inoculation amount of the selenium-enriched yeast is 5%, adding 20mL of a calcium chloride solution containing 12wt% of calcium ions, performing fermentation culture at 38 ℃ for 18h under the condition of micro-hypoxia, then adding 10mL of a vitamin solution, continuing fermentation culture at 38 ℃ for 24h, filtering through a microfiltration membrane with the pore size range of 0.5 mu m, separating and removing non-hydrolyzed insoluble components which cannot permeate the membrane, concentrating through a nanofiltration membrane with the pore size range of not more than 2nm, and performing freeze drying to prepare the metabolism promoting and oxidation resisting oat protein peptide;
the vitamin solution is an aqueous solution containing 5wt% of vitamin B1 and 3wt% of vitamin B12;
the micro-anoxic condition comprises 12% of oxygen, 5% of carbon dioxide and the balance of nitrogen, wherein the volume percentage is;
the enzyme deactivation method comprises 1500W ultrasonic treatment for 20 min.
Example 3
The embodiment provides a metabolism promoting and antioxidant oat protein peptide, which specifically comprises the following steps:
s1, extracting oat protein: cleaning 100g of oat, drying, crushing, sieving with a 100-mesh sieve to obtain oat powder, adding the oat powder into 400mL of trichloroacetic acid-acetone-acetonitrile solution, uniformly mixing, precipitating for 1h, centrifuging at 10000r/min for 10min, and adding 72g of insoluble substances into 220mL of acetone-acetonitrile solution; mixing uniformly, precipitating for 1.5h, centrifuging at 10000r/min for 10min, washing 53g of insoluble substances, drying at 60 ℃ for 2h, adding 190mL of lysate for cracking for 3h, taking supernatant, and concentrating by an ultrafiltration membrane with the pore diameter of 4000D to obtain an oat protein extract;
the lysis solution is an aqueous solution containing 4mol/L urea, 1.5mol/L thiourea and 0.7wt% dithiothreitol;
trichloroacetic acid in the trichloroacetic acid-acetone-acetonitrile solution: acetone: the volume ratio of acetonitrile is 0.7: 10: 4;
acetone in the acetone-acetonitrile solution: the volume ratio of the acetonitrile is 4: 5;
s2, primary enzymolysis: adjusting the pH value of 100g of the oat protein extract prepared in the step S1 to 3, heating to the temperature of 37 ℃, adding 3g of pepsin and 5g of acid protease, carrying out enzymolysis for 2h, inactivating enzymes, and filtering to obtain a filtrate, namely an oat protein first-level enzymolysis liquid;
s3, secondary enzymolysis: adjusting the pH value of 100g of the first-stage enzymatic hydrolysate of the oat protein prepared in the step S2 to 6.7, heating to 52 ℃, adding 3.5g of neutral protease and 5g of papain, carrying out enzymolysis for 3h, inactivating enzyme, and filtering to obtain a filtrate, namely a second-stage enzymatic hydrolysate of the oat protein;
s4, three-stage enzymolysis: adjusting the pH value of 100g of the filtrate prepared in the step S3 to be the oat protein secondary enzymolysis liquid to be 8.5, heating to 50 ℃, adding 4g of alkaline protease and 2g of flavourzyme, performing enzymolysis for 1 hour, inactivating enzyme, and filtering to obtain a filtrate which is the oat protein tertiary enzymolysis liquid;
s5, activating strains: inoculating Lactobacillus plantarum, Bacillus coagulans and selenium-rich yeast to Gao's medium, culturing under anoxic condition at 37 deg.C for 21 hr, and culturing to obtain strain seed solution with a strain content of 10 8 cfu/mL;
S6, primary fermentation: inoculating strain seed solutions of lactobacillus plantarum and bacillus coagulans into 100mL of the oat protein three-level enzymolysis solution prepared in the step S4, wherein the inoculation amounts of the lactobacillus plantarum and the bacillus coagulans are respectively 3.5% and 2%, and performing fermentation culture at the temperature of 37 ℃ for 30h under the condition of micro-hypoxia to obtain an oat protein first-level fermentation product;
s7, secondary fermentation: inoculating selenium-enriched yeast strain seed liquid to 100mL of oat protein primary fermentation product prepared in the step S6, wherein the inoculation amount of the selenium-enriched yeast is 4%, adding 15mL of calcium chloride solution containing 10wt% of calcium ions, performing fermentation culture at 37 ℃ for 16h under the condition of micro-hypoxia, then adding 7mL of vitamin solution, continuing fermentation culture at 37 ℃ for 22h, filtering through a microfiltration membrane with the pore size range of 0.3 mu m, separating and removing non-hydrolyzed insoluble components which cannot permeate the membrane, concentrating through a nanofiltration membrane with the pore size range of not more than 2nm, and performing freeze drying to prepare metabolism promoting and oxidation resisting oat protein peptide;
the vitamin solution is an aqueous solution containing 3.5wt% of vitamin B1 and 2wt% of vitamin B12;
the micro-anoxic condition comprises 9% of oxygen, 4% of carbon dioxide and the balance of nitrogen, wherein the volume percentage is;
the enzyme deactivation method is 1250W ultrasonic treatment for 17 min.
Example 4
Compared to example 3, the trichloroacetic acid-acetone-acetonitrile solution in step S1 was replaced by a trichloroacetic acid-acetone solution, trichloroacetic acid: the volume ratio of acetone is 0.7: 14, all other conditions were unchanged.
Example 5
In step S7, 15mL of a calcium chloride solution containing 10wt% of calcium ions was not added, and the other conditions were not changed, as compared with example 3.
The method comprises the following specific steps:
s7, secondary fermentation: inoculating selenium-enriched yeast strain seed liquid to 100mL of the oat protein primary fermentation product prepared in the step S6, wherein the inoculation amount of the selenium-enriched yeast is 4%, performing fermentation culture at 37 ℃ for 16h under the condition of micro-hypoxia, adding 7mL of vitamin solution, continuing performing fermentation culture at 37 ℃ for 22h, filtering through a microfiltration membrane with the pore size range of 0.3 mu m, separating and removing non-hydrolyzed insoluble components which cannot permeate the membrane, concentrating through a nanofiltration membrane with the pore size range of not more than 2nm, and performing freeze drying to obtain the metabolism promoting and oxidation resisting oat protein peptide.
Example 6
In step S7, 7mL of the vitamin solution was not added, compared to example 3, and the other conditions were not changed.
The method comprises the following specific steps:
s7, secondary fermentation: inoculating selenium-enriched yeast strain seed liquid to 100mL of oat protein primary fermentation product prepared in the step S6, wherein the inoculation amount of the selenium-enriched yeast is 4%, adding 15mL of calcium chloride solution containing 10wt% of calcium ions, performing fermentation culture at 37 ℃ for 38h under the condition of micro-hypoxia, filtering through a microfiltration membrane with the aperture range of 0.3 mu m, separating and removing non-hydrolyzed insoluble components which cannot permeate through the membrane, concentrating through a nanofiltration membrane with the aperture range of not more than 2nm, and freeze-drying to obtain the metabolism promoting and oxidation resisting oat protein peptide.
Example 7
In step S7, 15mL of calcium chloride solution containing 10wt% calcium ions and 7mL of vitamin solution were not added, as compared with example 3, and other conditions were not changed.
The method comprises the following specific steps:
s7, secondary fermentation: inoculating the selenium-enriched yeast strain seed liquid to 100mL of the oat protein primary fermentation product prepared in the step S6, wherein the inoculation amount of the selenium-enriched yeast is 4%, performing fermentation culture at 37 ℃ for 38h under the condition of micro-hypoxia, filtering through a microfiltration membrane with the pore size range of 0.3 mu m, separating and removing non-hydrolyzed insoluble components which cannot permeate through the membrane, then concentrating through a nanofiltration membrane with the pore size range of not more than 2nm, and performing freeze drying to prepare the metabolism promoting and oxidation resisting oat protein peptide.
Comparative example 1
Compared with the embodiment 3, the first-stage enzymolysis of the step S1 is not carried out, and other conditions are not changed.
Comparative example 2
Compared with the example 3, the secondary enzymolysis of the step S2 is not carried out, and other conditions are not changed.
Comparative example 3
Compared with the example 3, the tertiary enzymolysis of the step S3 is not carried out, and other conditions are not changed.
Comparative example 4
Compared with the example 3, the steps S1-S3 are not carried out, and other conditions are not changed.
Comparative example 5
Compared with example 3, no lactobacillus plantarum was used in step S6, and other conditions were unchanged.
Comparative example 6
In step S6, Bacillus coagulans was not inoculated, and other conditions were not changed, as compared with example 3.
Comparative example 7
Step S6 was not performed, and other conditions were not changed, as compared with example 3.
Comparative example 8
Step S7 was not performed, and other conditions were not changed, as compared with example 3.
Comparative example 9
Compared with example 3, common baker' S yeast (available from Angel Yeast Co., Ltd.) was used in step S7 in place of the selenium-enriched yeast, and other conditions were not changed.
Comparative example 10
As compared with example 3, the fermentation steps S6-S7 were not performed, and other conditions were not changed.
Test example 1
The protein content of the oat protein extract obtained in step S1 of examples 1-4 was measured according to GB 5009.5-2016, "determination of proteins in national food safety standards".
The extraction rate R of the oat protein is calculated according to the following formula:
R=m/M×100%
in the formula: r is protein extraction rate,%; m is the total mass of protein in the extracting solution, g; m is the protein mass in oat, g.
The results are shown in Table 1.
TABLE 1
As can be seen from the above table, the method described in step S1 in examples 1-3 of the present invention provides a higher extraction rate of oat protein.
Test example 2 determination of molecular weight distribution
Reference is made to the following documents: li Y H, et al, analytical and free radial-scanning activities of Chippea Proteins Hydrosate (CPH) [ J ]. Food Chemistry, 2008, 106 (2): 444-450.
The pro-metabolic and antioxidant avenin peptides prepared in examples 1 to 7 and comparative examples 1 to 10 were prepared into a sample solution of 2mg/mL to be analyzed, and filtered through a microfiltration membrane. A10. mu.L sample of the sample to be analyzed was taken with a hand-operated sampler, injected into a TSK gel G2000 SWXL column, and eluted with a 42% acetonitrile solution containing 0.15% trifluoroacetic acid at a flow rate of 0.2mL/min and a detection wavelength of 214 nm. The standard curve was obtained by plotting elution time against log molecular weight using standard aprotinin (6512D), bactetracin (1423D), WPWW (tetrapeptide, 674D), NCS (tripeptide, 322D), Gly-Ser (dipeptide, 146D): y = -0.1892x +6.5172 (y: logMW, x: elution time), the results are shown in Table 2.
TABLE 2
As can be seen from the above table, the molecular weight of the pro-metabolic and antioxidant avenin peptides prepared in examples 1-3 of the present invention is mainly below 1000D, and studies have shown that small molecular peptides are more easily absorbed, which indicates that the polypeptide obtained from the pro-metabolic and antioxidant avenin peptides is smaller in molecular weight and mainly exists in a form of less than pentapeptide.
Test example 3 Oxidation resistance test
1. Determination of DPPH radical scavenging Capacity
Preparing the metabolism promoting and oxidation resisting avenin peptides prepared in the examples 1-7 and the comparative examples 1-10 into 10mg/mL sample solution, uniformly mixing 1mL sample solution and 4mL of 0.12mmol/L DPPH solution, sealing and standing at room temperature for 30min, detecting the absorbance at the wavelength of 517nm, and using a comparison group to be 10mg/mL vitamin C solution, wherein the clearance rate calculation formula is as follows:
clearance (%) = (1-a) 1 -A 2 )/A 3 ×100%
In the formula: a. the 1 Is the absorbance of the solution after the sample is added; a. the 2 Is the absorbance of the sample; a. the 3 Absorbance of the solution without sample.
The results are shown in Table 3.
TABLE 3
As can be seen from the above table, the oat protein peptides of examples 1-3 of the present invention have excellent DPPH radical scavenging effect.
2. Determination of OH free radical scavenging Capacity
0.1mL of 10mmol/LFeSO was added to the centrifuge tube in sequence 4 ·7H 2 O, 0.1mL of 10mmol/L EDTA, 0.1mL of 10 mmol/L2-deoxyribose, 0.1mL of 10mg/mL of the pro-metabolic, antioxidant avenin peptide solutions prepared in examples 1 to 7 and comparative examples 1 to 10, 0.5mL of 0.1mol/L PBS (pH = 7.4) and 0.1mL of 10mmol/L H 2 O 2 After being mixed uniformly, the mixture is reacted in a constant temperature water bath kettle at 37 ℃ for 60min, then 0.5mL of 2.8 percent trichloroacetic acid and 0.5mL of 1 percent thiobarbituric acid are added, boiled in boiling water for 15min, cooled in cold water, and the absorbance is measured under the condition of 532 nm. An equal amount of distilled water was used as a blank, and a 10mg/mL vitamin C solution was used as a control.
The clearance calculation formula is as follows:
clearance (%) = (a) 0 -A s )/A 0 ×100%
In the formula: a. the 0 Absorbance of blank group, A s And the absorbance of the sample group to be detected.
The results are shown in Table 4.
TABLE 4
As can be seen from the above table, the oat protein peptides with metabolism promoting and antioxidant effects prepared in examples 1-3 of the present invention have excellent OH free radical scavenging effects.
3. Determination of superoxide anion radical scavenging ability
The pro-metabolic and anti-oxidative avenin peptides prepared in examples 1-7 and comparative examples 1-10 were prepared as 10mg/mL sample solutions, 1mL sample solution and 1.85mL 50mmol/L Tris-HCl (pH = 8.2) were placed in a water bath at 25 ℃ for reaction for 10min, then 0.15mL 3mmol/L pyrogallol (prepared in 10mmol/L HCl) was added, and the absorbance of the solution was measured at 325nm, and the absorbance was read every 30s until 4 min. Determining the oxidation rate of pyrogallol (A) from the rate of change of absorbance Sample (I) ) The oxidation rate of pyrogallol (A) was measured by replacing the sample with an equal volume of distilled water Blank space ) As a blank group, a 10mg/mL vitamin C solution was used as a control group. The clearance calculation formula is as follows:
clearance (%) = (1-a) Sample (I) /A Blank space )×100%
In the formula: a. the Blank space Absorbance for blank group; a. the Sample (I) Is the absorbance of the sample to be measured.
The results are shown in Table 5.
TABLE 5
As can be seen from the above table, the oat protein peptides with metabolism promoting and oxidation resisting effects prepared in the embodiments 1-3 of the present invention have a very good superoxide anion free radical scavenging effect.
In conclusion, the oat protein peptides with metabolism promoting and oxidation resisting effects prepared in examples 1-3 of the present invention have excellent oxidation resisting effects.
Test example 4 weight loss mouse test
After 1 week acclimation of C57 mice, the mice were randomly divided into 19 groups: normal control group, high fat diet group, examples 1 to 7 groups, comparative examples 1 to 10 groups, 10 mice per group. Normal control group was given normal mouse diet (purchased from multi-meter agriculture technology ltd, linqing) and other groups were given high fat diet (purchased from cooperative medical bioengineering ltd, jiangsu province, 60% fat content, free diet). Examples 1-5 and comparative examples 1-10 groups were additionally administered the prepared metabolism-promoting, antioxidant avenin peptide 10g/kg body weight daily, and the normal control group, the high fat diet group, and the same amount of water. All mice were continuously fed for 8 weeks, during which the animal body weight was measured 1 time per week at a fixed time and recorded, and at the end of 8 weeks, all animals were fasted overnight, anesthetized with 10% chloral hydrate intraperitoneal injection (100 μ L/10g body weight), blood was collected from the heart, left at room temperature for 30min, centrifuged, and serum TG, TC, HDL, LDL were measured by an enzymatic method.
The results are shown in FIG. 1 and Table 6.
As can be seen from FIG. 1, the mice in the groups of examples 1-3 had their body weights significantly controlled after eating the prepared metabolism-promoting, antioxidant avenin peptides, and the body weights were significantly lower than those of the high-fat diet group.
TABLE 6
As can be seen from the above table, the TG content of the mice fed with the high-fat feed is obviously lower than that of the mice in the normal control group, and the TC, HDL and LDL contents are obviously higher than that of the mice in the normal control group, and the content of TG in the metabolism-promoting and oxidation-resisting oat protein peptides prepared by the examples 1-3 of the invention is obviously improved, and the content of TC, HDL and LDL is obviously reduced, so that the metabolism-promoting and oxidation-resisting oat protein peptides prepared by the examples 1-3 of the invention have better effects of controlling blood fat, promoting in vivo metabolism and controlling body weight.
Example 4 compared to example 3, the trichloroacetic acid-acetone-acetonitrile solution in step S1 was replaced by a trichloroacetic acid-acetone solution, trichloroacetic acid: the volume ratio of acetone is 0.7: 14. the extracted protein content is obviously reduced, the antioxidation effect is reduced, the weight loss effect is reduced, and the blood fat reducing effect is reduced. The oat flour is directly extracted by trichloroacetic acid-acetone-acetonitrile solution/acetone-acetonitrile solution for the second time, the trichloroacetic acid-acetone-acetonitrile solution is adopted to replace the traditional trichloroacetic acid-acetone solution, the protein extraction rate is higher, the nitrogen element on the cyano group contained in the adopted acetonitrile is easy to form hydrogen bond with the carboxylic acid structure of protein amino acid, so that the protein extraction in the oat flour is promoted and is precipitated in the presence of acetone, the extraction time is short, the repetition rate is high, and the influence of metabolic substances in a sample can be reduced and the protein loss can be reduced.
Example 5 compared to example 3, no 15mL of calcium chloride solution containing 10wt% calcium ions was added in step S7. Example 6 compared to example 3, no 7mL vitamin solution was added in step S7. Example 7 compared to example 3, 15mL of calcium chloride solution containing 10wt% calcium ions and 7mL of vitamin solution were not added in step S7. The content of the prepared protein peptide less than 1000D is reduced, and the effects of resisting oxidation, reducing weight and reducing blood fat are reduced. In comparative example 8, compared with example 3, the content of the produced protein peptide less than 500D was significantly decreased without performing step S7, and the antioxidant effect, weight loss effect, and blood lipid lowering effect were significantly decreased. Comparative example 9 compared with example 3, the antioxidant effect and the weight loss effect of the protein peptide prepared by using common baker' S yeast (purchased from Angel Yeast Co., Ltd.) instead of the selenium-enriched yeast in step S7 were reduced. Adding selenium-enriched yeast into the oat protein primary fermentation product, further performing enzymolysis, and simultaneously chelating product polypeptide with selenium mineral elements in organic selenium substances to form oat protein peptide-selenium chelate, wherein the chelate of the oat protein peptide and the selenium element is formed by mutual coordination between the selenium element and N-terminal amino, amino acid side chain, C-terminal carboxyl and carbonyl and imino in a peptide chain in the oat protein peptide. Compared with a chelate formed by the interaction of simple amino acid and selenium element, the chelate of the oat protein peptide and the selenium element has better stability and matching rate, has the advantages of high biological benefit, excellent absorption effect, excellent nutrition and the like, and can combine the complementary functional activities of the oat protein peptide and the selenium element, such as metabolism promotion, oxidation resistance, inflammation diminishing, bacteria resistance, immunity enhancement, blood pressure reduction, blood fat reduction, blood sugar reduction, weight losing, fat reduction, weight control and the like.
Compared with the example 3, the comparative examples 1, 2 and 3 do not carry out the first-stage enzymolysis of the step S1, the second-stage enzymolysis of the step S2 and the third-stage enzymolysis of the step S3 respectively, so that the relative content of the small molecular weight of the prepared protein peptide is reduced, and the antioxidant effect is obviously reduced. Compared with the example 3, the comparative example 4 has no steps of S1-S3 enzymolysis, the relative content of the small molecular weight of the prepared protein peptide is obviously reduced, the antioxidation effect is obviously reduced, and the weight-losing effect and the blood fat reducing effect are obviously reduced. The prepared oat protein extract is respectively subjected to enzymolysis under acidic, neutral and alkaline conditions, the acidic pepsin and the acidic protease which are suitable for the acidity are used for enzymolysis under the acidic condition, the proportion of small-molecule peptides in hydrolysate is very high, and the produced polypeptides are almost all small-molecule peptides; under neutral conditions, the enzymolysis is carried out by neutral protease suitable for neutral and papain, the neutral protease is a metal protease, the peptide bond between leucine and phenylalanine is preferentially cut, the papain can decompose the peptide bond in a hydrophobic region, including threonine, tryptophan, phenylalanine and the like, the hydrolysis degree of the enzymolysis product is high, the antioxidant activity is high, under alkaline conditions, the enzymolysis is carried out by alkaline protease suitable for alkaline and flavourzyme, the alkaline protease can decompose the peptide bond, including phenylalanine, tyrosine, tryptophan and lysine carboxyl, and the flavourzyme can preferentially break the peptide bond between leucine and proline or between proline and proline; the enzymolysis speed is fast, the enzymolysis effect is good, the yield of hydrolysate small peptides is high, the polypeptide after enzymolysis has higher emulsification stability, after three-stage enzymolysis, most of oat protein in the oat protein extracting solution is enzymolyzed into micromolecular short peptides and oligopeptide substances, and the antioxidant activity is very good.
Comparative examples 5 and 6 compared with example 3, no Lactobacillus plantarum or Bacillus coagulans was used in step S6. Compared with example 3, the comparative example 7 has no step S6, the relative content of the prepared protein peptide less than 1000D is obviously reduced, and the weight-reducing effect and the blood fat-reducing effect are reduced. The prepared third-level enzymolysis liquid of the oat protein also comprises a plurality of long-chain protein molecules and unhydrolyzed protein, lactobacillus plantarum and bacillus coagulans are further added for fermentation, probiotics ferment and hydrolyze the protein molecules further, and most of the unhydrolyzed long-chain protein is hydrolyzed into amino acid, short peptide, oligopeptide or polypeptide substances, so that a first-level fermentation product of the oat protein is prepared.
Comparative example 10 compared to example 3, the fermentation steps S6-S7 were not performed. The relative content of the prepared protein peptide less than 1000D is obviously reduced, and the effects of oxidation resistance, weight loss and blood fat reduction are obviously reduced. The oat protein peptide with the functions of promoting metabolism and resisting oxidation, which is prepared by the method disclosed by the invention, comprises an oat protein peptide-selenium chelate, and the oat protein peptide has an excellent anti-oxidation effect after detection, wherein most of the oat protein peptide is short peptide and oligopeptide substances with low molecular weight, and the short peptide and oligopeptide substances with low molecular weight are more easily close to free radicals than bulky parent proteins of the oat protein peptide and oligopeptide substances, and can inhibit peroxidation mediated by the free radicals. The short peptide and oligopeptide substances provide hydrogen atoms or electrons through peptide bonds and hydroxyl groups of the substances, and free radicals lacking hydrogen ions or electrons are eliminated, so that the destructive effect on biological molecules is eliminated; at the same time, the formation of ROS and free radicals can be inhibited by inhibiting certain pro-oxidases and chelating transition metal ions involved in catalyzing the generation of free radicals. The short peptide and oligopeptide substances can also inhibit the conversion of free radicals into hydrogen peroxide, and can be decomposed into harmless metabolites such as water and oxygen by endogenous antioxidants (including superoxide dismutase, catalase and glutathione), thereby having high antioxidant effect.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.
Claims (10)
1. A preparation method of oat protein peptide with metabolism promotion and oxidation resistance is characterized by comprising the steps of crushing oat, extracting by using an organic solvent to obtain oat protein, performing primary enzymolysis by using pepsin and acid protease, performing secondary enzymolysis by using neutral protease and papain, performing tertiary enzymolysis by using alkaline protease and flavourzyme to obtain tertiary enzymolysis liquid of the oat protein, fermenting by using lactobacillus plantarum and bacillus coagulans to obtain a primary fermentation product of the oat protein, and fermenting by using selenium-enriched yeast to obtain the oat protein peptide with metabolism promotion and oxidation resistance.
2. The method of claim 1, comprising the steps of:
s1, extracting oat protein: cleaning oat, drying, crushing, sieving to obtain oat powder, adding the oat powder into a trichloroacetic acid-acetone-acetonitrile solution, uniformly mixing, precipitating for a first time period, centrifuging, adding an insoluble substance into the acetone-acetonitrile solution, uniformly mixing, precipitating for a second time period, centrifuging, washing the insoluble substance, drying, adding the insoluble substance into a lysate for cracking, taking a supernatant, and concentrating by using an ultrafiltration membrane to obtain an oat protein extracting solution;
s2, primary enzymolysis: adjusting the pH value of the oat protein extract prepared in the step S1 to 2.5-3.5, heating to the temperature of 35-40 ℃, adding pepsin and acid protease, performing enzymolysis, inactivating enzymes, and filtering to obtain a filtrate, namely an oat protein first-level enzymolysis liquid;
s3, secondary enzymolysis: adjusting the pH value of the first-stage oat protein enzymolysis liquid prepared in the step S2 to 6.5-7, heating to 50-55 ℃, adding neutral protease and papain, performing enzymolysis, inactivating enzymes, and filtering to obtain a filtrate, namely a second-stage oat protein enzymolysis liquid;
s4, three-stage enzymolysis: adjusting the pH value of the filtrate obtained in the step S3 to be the second-level enzymatic hydrolysate of the oat protein to be 8-9, heating to the temperature of 45-55 ℃, adding alkaline protease and flavourzyme, carrying out enzymolysis, enzyme deactivation and filtration, wherein the filtrate is the third-level enzymatic hydrolysate of the oat protein;
s5, activating strains: respectively inoculating lactobacillus plantarum, bacillus coagulans and selenium-enriched yeast to a Gauss culture medium, culturing under a micro-anoxic condition, and respectively culturing into strain seed solutions;
s6, primary fermentation: inoculating strain seed solutions of lactobacillus plantarum and bacillus coagulans to the oat protein three-level enzymatic hydrolysate prepared in the step S4, and performing fermentation culture under a micro-anoxic condition to obtain an oat protein first-level fermentation product;
s7, secondary fermentation: inoculating the selenium-enriched yeast strain seed liquid to the oat protein primary fermentation product prepared in the step S6, adding a solution containing calcium ions, carrying out fermentation culture under the condition of hypoxia for a third time period, then adding a vitamin solution, continuing fermentation culture for a fourth time period, filtering by a microfiltration membrane, separating and removing non-hydrolyzed insoluble components which cannot penetrate through the membrane, then concentrating by a nanofiltration membrane, and carrying out freeze drying to prepare the metabolism promoting and oxidation resisting oat protein peptide.
3. The preparation method of claim 2, wherein the solid-to-liquid ratio of the oat flour and the trichloroacetic acid-acetone-acetonitrile solution in the step S1 is 1: 3-5 g/mL; trichloroacetic acid in the trichloroacetic acid-acetone-acetonitrile solution: acetone: the volume ratio of the acetonitrile is 0.5-1: 7-12: 3-5; the solid-liquid ratio of the insoluble substances to the acetone-acetonitrile solution is 1:2-4g/mL, and the ratio of acetone in the acetone-acetonitrile solution is as follows: the volume ratio of the acetonitrile is 3-5: 4-7; the first time period is 0.5-1.5 h; the second time period is 1-2 h; the lysis solution is an aqueous solution containing 3-5mol/L urea, 1-2mol/L thiourea and 0.5-1wt% dithiothreitol; the cracking time is 2-4 h; the solid-liquid ratio of the insoluble substance to the lysate is 1:2-5 g/mL; the pore diameter of the ultrafiltration membrane is 3000-5000D.
4. The preparation method according to claim 2, wherein the mass ratio of the oat protein extract, the pepsin and the acid protease in the step S2 is 100:1-5: 3-7; the enzymolysis time is 1-3 h; in the step S3, the mass ratio of the oat protein primary enzymolysis liquid to the neutral protease to the papain is 100:2-5:3-6, and the enzymolysis time is 2-4 h; in the step S4, the mass ratio of the oat protein secondary enzymolysis liquid to the neutral protease to the papain is 100:3-5:1-3, and the enzymolysis time is 0.5-1.5 h.
5. The method of claim 2, wherein the micro-anoxic conditions are an oxygen content of 5-12%, a carbon dioxide content of 3-5%, and the balance nitrogen, wherein% is volume percent; the method for killing the enzyme comprises 1000-1500W ultrasonic treatment for 15-20 min.
6. The method according to claim 2, wherein the cultivation temperature in step S5 is 35-40 ℃, the cultivation time is 18-24 hours, and the bacteria content of the seed solution of the strain is 10 7 -10 9 cfu/mL; in the step S6, the inoculation amounts of the lactobacillus plantarum and the bacillus coagulans are respectively 2-5% and 1-3%; the fermentation culture condition is that the temperature is 36-38 deg.C, and the time is 24-36 h.
7. The method according to claim 2, wherein the inoculation amount of the selenium-enriched yeast in step S7 is 3-5%, and the volume ratio of the oat protein primary fermentation product, the solution containing calcium ions and the vitamin solution is 10: 1-2: 0.5 to 1; the calcium ion concentration in the solution containing calcium ions is 5-12wt%, and the vitamin solution is an aqueous solution containing 2-5wt% of vitamin B1 and 1-3wt% of vitamin B12; the fermentation culture condition is 36-38 ℃, and the third time period is 12-18 h; the fourth time period is 18-24 h; the aperture range of the micro-filtration membrane is 0.1-0.5 mu m, and the aperture range of the nano-filtration membrane is not more than 2 nm.
8. The preparation method according to claim 2, characterized by comprising the following steps:
s1, extracting oat protein: washing oat, drying, crushing and sieving to obtain oat powder, adding the oat powder into trichloroacetic acid-acetone-acetonitrile solution, wherein the solid-to-liquid ratio of the oat powder to the trichloroacetic acid-acetone-acetonitrile solution is 1: 3-5g/mL, wherein the ratio of trichloroacetic acid in the trichloroacetic acid-acetone-acetonitrile solution is as follows: acetone: the volume ratio of the acetonitrile is 0.5-1: 7-12:3-5, uniformly mixing, precipitating for 0.5-1.5h, centrifuging, adding an insoluble substance into an acetone-acetonitrile solution, wherein the solid-to-liquid ratio of the insoluble substance to the acetone-acetonitrile solution is 1:2-4g/mL, and the mass ratio of acetone in the acetone-acetonitrile solution is as follows: the volume ratio of acetonitrile is 3-5:4-7, uniformly mixing, precipitating for 1-2h, centrifuging, washing insoluble substances, drying, adding the dried insoluble substances into a lysate for cracking for 2-4h, wherein the solid-to-liquid ratio of the insoluble substances to the lysate is 1:2-5g/mL, the lysate is an aqueous solution containing 3-5mol/L urea, 1-2mol/L thiourea and 0.5-1wt% dithiothreitol, taking supernatant, and concentrating through an ultrafiltration membrane with the pore diameter of 3000-;
s2, primary enzymolysis: adjusting the pH value of 100 parts by weight of the oat protein extract prepared in the step S1 to 2.5-3.5, heating to the temperature of 35-40 ℃, adding 1-5 parts by weight of pepsin and 3-7 parts by weight of acid protease, performing enzymolysis for 1-3h, inactivating enzymes, and filtering to obtain a filtrate, namely an oat protein first-stage enzymolysis liquid;
s3, secondary enzymolysis: adjusting the pH value of 100 parts by weight of the first-stage enzymatic hydrolysate of the oat protein prepared in the step S2 to 6.5-7, heating to 50-55 ℃, adding 2-5 parts by weight of neutral protease and 3-6 parts by weight of papain, carrying out enzymolysis for 2-4h, inactivating enzyme, and filtering to obtain filtrate which is a second-stage enzymatic hydrolysate of the oat protein;
s4, three-stage enzymolysis: adjusting the pH value of 100 parts by weight of the filtrate prepared in the step S3 to be the oat protein secondary enzymolysis liquid to 8-9, heating to 45-55 ℃, adding 3-5 parts by weight of alkaline protease and 1-3 parts by weight of flavor protease, carrying out enzymolysis for 0.5-1.5h, inactivating enzymes, and filtering to obtain a filtrate which is the oat protein tertiary enzymolysis liquid;
s5, strain activation: respectively inoculating Lactobacillus plantarum, Bacillus coagulans and selenium-rich yeast to Gao's medium, culturing under anoxia condition at 35-40 deg.C for 18-24 hr to obtain strain seed solutions with a bacteria content of 10 7 -10 9 cfu/mL;
S6, primary fermentation: inoculating strain seed solutions of lactobacillus plantarum and bacillus coagulans to the oat protein tertiary enzymolysis solution prepared in the step S4, wherein the inoculation amounts of lactobacillus plantarum and bacillus coagulans are respectively 2-5% and 1-3%, and the fermentation culture is carried out for 24-36h at the temperature of 36-38 ℃ under the condition of micro-hypoxia, so as to obtain an oat protein primary fermentation product;
s7, secondary fermentation: inoculating selenium-enriched yeast strain seed liquid to 10 volume parts of the oat protein primary fermentation product prepared in the step S6, wherein the inoculation amount of the selenium-enriched yeast is 3-5%, adding 1-2 volume parts of a solution containing 5-12wt% of calcium ions, performing fermentation culture at 36-38 ℃ for 12-18h under the condition of micro-hypoxia, then adding 0.5-1 volume part of a vitamin solution, wherein the vitamin solution is an aqueous solution containing 2-5wt% of vitamin B1 and 1-3wt% of vitamin B12, continuing fermentation culture at 36-38 ℃ for 18-24h, filtering through a microfiltration membrane with the pore size of 0.1-0.5 mu m, separating and removing non-hydrolyzed insoluble components which cannot permeate through the membrane, then concentrating through a nanofiltration membrane with the pore size of not more than 2nm, freeze-drying, preparing oat protein peptide with metabolism promoting and antioxidant effects;
the micro-anoxic condition comprises 5-12% of oxygen, 3-5% of carbon dioxide and the balance of nitrogen, wherein the volume percentage is;
the enzyme deactivation method comprises 1000-1500W ultrasonic treatment for 15-20 min.
9. A metabolically-enhanced, antioxidative avenin peptide produced by the method of any one of claims 1-8.
10. Use of the pro-metabolic, anti-oxidant avenin peptide of claim 9 in the manufacture of a weight loss, weight control product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210946529.7A CN115011660B (en) | 2022-08-09 | 2022-08-09 | Metabolism promoting and oxidation resisting oat protein peptide and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210946529.7A CN115011660B (en) | 2022-08-09 | 2022-08-09 | Metabolism promoting and oxidation resisting oat protein peptide and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115011660A true CN115011660A (en) | 2022-09-06 |
CN115011660B CN115011660B (en) | 2022-10-28 |
Family
ID=83065921
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210946529.7A Active CN115011660B (en) | 2022-08-09 | 2022-08-09 | Metabolism promoting and oxidation resisting oat protein peptide and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115011660B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115624186A (en) * | 2022-12-01 | 2023-01-20 | 北京幸福能量健康科技有限公司 | High-protein low-GI composite grain composition and preparation method and application thereof |
CN117481250A (en) * | 2023-12-29 | 2024-02-02 | 北京幸福能量健康科技有限公司 | Yeast protein composition capable of replacing whey protein, preparation method and application |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102212600A (en) * | 2011-04-29 | 2011-10-12 | 北京工商大学 | Method for preparing antioxidant peptides from oats by utilizing enzymatic membrane reactor |
WO2019104761A1 (en) * | 2017-11-30 | 2019-06-06 | 江南大学 | Method for fermenting, highly producing, and preparing debittered rice peptide from recombinant prolyl aminopeptidase |
CN111264826A (en) * | 2020-03-17 | 2020-06-12 | 广西壮族自治区农业科学院 | Preparation method of walnut protein peptide-selenium chelate for regulating intestinal flora |
CN111378709A (en) * | 2020-03-20 | 2020-07-07 | 广西壮族自治区农业科学院 | Preparation method of corn polypeptide-selenium chelate |
CN111938054A (en) * | 2020-08-19 | 2020-11-17 | 中国科学院微生物研究所 | Organic oat functional beverage and preparation method thereof |
CN114703247A (en) * | 2022-06-07 | 2022-07-05 | 北京幸福能量健康科技有限公司 | High-absorptivity composite protein composition and preparation method and application thereof |
-
2022
- 2022-08-09 CN CN202210946529.7A patent/CN115011660B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102212600A (en) * | 2011-04-29 | 2011-10-12 | 北京工商大学 | Method for preparing antioxidant peptides from oats by utilizing enzymatic membrane reactor |
WO2019104761A1 (en) * | 2017-11-30 | 2019-06-06 | 江南大学 | Method for fermenting, highly producing, and preparing debittered rice peptide from recombinant prolyl aminopeptidase |
CN111264826A (en) * | 2020-03-17 | 2020-06-12 | 广西壮族自治区农业科学院 | Preparation method of walnut protein peptide-selenium chelate for regulating intestinal flora |
CN111378709A (en) * | 2020-03-20 | 2020-07-07 | 广西壮族自治区农业科学院 | Preparation method of corn polypeptide-selenium chelate |
CN111938054A (en) * | 2020-08-19 | 2020-11-17 | 中国科学院微生物研究所 | Organic oat functional beverage and preparation method thereof |
CN114703247A (en) * | 2022-06-07 | 2022-07-05 | 北京幸福能量健康科技有限公司 | High-absorptivity composite protein composition and preparation method and application thereof |
Non-Patent Citations (3)
Title |
---|
于国萍等: "双酶法制得米糠蛋白肽抗氧化组分的分离纯化", 《食品工业》 * |
张根生等: "抗氧化活性林蛙胎卵多肽酶解酶的筛选", 《食品科学》 * |
郑召君等: "限制性酶解调控燕麦蛋白结构特性与抗氧化功能", 《食品科学》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115624186A (en) * | 2022-12-01 | 2023-01-20 | 北京幸福能量健康科技有限公司 | High-protein low-GI composite grain composition and preparation method and application thereof |
CN117481250A (en) * | 2023-12-29 | 2024-02-02 | 北京幸福能量健康科技有限公司 | Yeast protein composition capable of replacing whey protein, preparation method and application |
Also Published As
Publication number | Publication date |
---|---|
CN115011660B (en) | 2022-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN115011660B (en) | Metabolism promoting and oxidation resisting oat protein peptide and preparation method and application thereof | |
CN108998488B (en) | Active royal jelly OCO polypeptide freeze-dried powder and preparation method thereof | |
US9609883B2 (en) | Method for producing wheat glutamine peptide | |
CN114480549B (en) | Bioactive peptide prepared from snail, and preparation method and application thereof | |
CN102048022A (en) | Soybean polypeptide without hydrolysis and bitter tastes as well as preparation method and application thereof | |
CN108893515B (en) | High F value oligopeptide and preparation method thereof | |
CN109468357A (en) | A kind of preparation method of spleen aminopeptide | |
CN102228125B (en) | Preparation method of algal active peptide | |
CN113249421A (en) | Golden-silk-royal chrysanthemum protein polypeptide and preparation and application thereof | |
CN112080542B (en) | Preparation method of low phenylalanine egg white protein peptide | |
CN105907826B (en) | Clean preparation method of plant polypeptide/protein | |
CN109504731B (en) | Preparation method of sheep placenta active peptide | |
CN109576331B (en) | Extraction method of wheat germ peptide | |
CN115057916B (en) | Pinctada martensii meat antioxidant polypeptide and preparation method and application thereof | |
CN113481270B (en) | Method for extracting glycopeptide from scallop skirt | |
CN113999884B (en) | Preparation method of turtle bioactive peptide | |
JPH068322B2 (en) | Pectin manufacturing method | |
EP0061556B1 (en) | Hemiron-enriched amino acid preparation and a process for the preparation of hemiron-enriched amino acid preparations from hemproteins | |
CN108517343A (en) | A kind of preparation method of the anti-oxidant protein peptides of Porphyra yezoensis | |
JP3850740B2 (en) | Non-protein nitrogen compound derived from milk, L-carnitine concentration method, L-carnitine concentrate and use thereof | |
JP2007151427A (en) | Albumen hydrolyzate richly containing cysteine, and food and drink containing the same | |
CN111778305B (en) | Spleen polypeptide composition for improving immunity and oral liquid | |
CN114836505B (en) | Small molecule anti-alcohol peptide and preparation method and application thereof | |
CN113502312B (en) | Method for extracting functional glycopeptides from scallop viscera degreasing residues | |
CN112608365B (en) | Weight-reducing fermented small-molecule peptide and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |